The ChinaCare Group Announces Engagement with Hailong Investment Co Ltd

03:03 EDT 4 Jul 2017 |

Hong Kong, Hong Kong S.A.R., July 04, 2017 --( The ChinaCare Group announced today that it has been engaged by Shanghai-based Hailong Investment Co Ltd to assist the firm in its expansion and acquisition activities. In this engagement, The ChinaCareGroup will provide due diligence and feasibility assessments of potential acquisitions under consideration by Hailong.

In announcing the engagement, The ChinaCare Group’s senior partner David Wood said, “For the past fourteen years, ChinaCare has been assisting clients in their efforts to introduce new healthcare projects in China. In this engagement CCG will be applying its considerable knowledge and expertise in the Chinese healthcare marketplace to assist Hailong in its investment strategy.” For additional information please consult the company’s website:

The ChinaCareGroup has been in existence since 2003 providing consulting, development and management services to the healthcare marketplace in China and Southeast Asia.


David Wood
Mobile: 86-13910589100

Contact Information:
The ChinaCareGroup
David Wood
Contact via Email

Read the full story here:

Press Release Distributed by

Original Article: The ChinaCare Group Announces Engagement with Hailong Investment Co Ltd


More From BioPortfolio on "The ChinaCare Group Announces Engagement with Hailong Investment Co Ltd"

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...